Synthetic bile acid composition, method, and preparation

A composition and compound technology, applied in the direction of drug combination, steroids, skin care preparations, etc., can solve the problem of undeveloped pharmaceutical grade composition of phytosterol-derived bile acids

Inactive Publication Date: 2016-11-09
艾尔健销售有限责任公司
View PDF14 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite extensive efforts in phytosterol research throughout history, no readily available pharmaceutical-grade compositions of phytosterol-derived bile acids have been developed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic bile acid composition, method, and preparation
  • Synthetic bile acid composition, method, and preparation
  • Synthetic bile acid composition, method, and preparation

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0027] definition

[0028] Throughout this disclosure, various publications, patents, and published patent specifications are hereby incorporated by reference by equivalents. The disclosures of these publications, patents, and published patent specifications are hereby incorporated by reference herein to more fully describe the state of the art to which this invention pertains.

[0029] Certain terms used herein have the meanings defined below. The singular forms "a, an" and "the" used in the specification and claims include both the singular and the plural unless the context clearly dictates otherwise.

[0030] Unless otherwise indicated, all numbers expressing quantities of ingredients, reaction conditions, etc. used in the specification and claims are to be understood in all instances as being modified by the term "about". Accordingly, unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations...

example

[0218] The various starting materials, intermediates and compounds of the preferred embodiments can be isolated and purified using conventional techniques such as precipitation, filtration, crystallization, evaporation, distillation, and chromatography, as appropriate. These compounds can be characterized using conventional methods such as melting point methods, mass spectrometry, nuclear magnetic resonance, and various other spectroscopic analyses.

[0219] Illustrative examples of steps for carrying out product synthesis in Scheme 1B of the first synthetic pathway are described in more detail below. Table 3 sets forth the abbreviations used in the Examples below and throughout the specification to express various compounds / moieties / devices / procedures / properties in exemplary reaction schemes and synthetic pathways.

[0220] table 3

[0221]

[0222]

[0223] General Procedures: Oxygen sensitive and moisture sensitive materials are handled in flame dried two-necked flas...

example 1

[0237] Preparation of androstane-3,11,17-trione (1.13)

[0238] 10% Pd / C (2.5 g, 5 wt%) was added to a solution of hydrocortisone (compound 1.12) (50.0 g, 138.12 mmol) in DMF (250 mL). The resulting slurry was hydrogenated in a Parr apparatus (50 psi) for 12h. After complete disappearance of the starting material as shown by TLC, the crude reaction mixture was filtered through a small plug of celite and the solvent was removed under vacuum. The crude product (48.0 g) was obtained in the form of a colorless solid.

[0239] NaBH 4 (2.1 g, 55.3 mmol) was added to a solution of EtOH (500 mL) and CH 2 Cl 2 (500 mL) in a solution of the above crude product (48.0 g, 131.86 mmol). After 1 h, acetone (50 mL) followed by water (150 mL) and NaIO were added sequentially 4 (70.5 g, 329.6 mmol). The mixture was stirred overnight at room temperature.

[0240] Distilled water (500 mL) was added and the mixture was extracted with ethyl acetate (3 x 250 mL). The ethyl acetate layer was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.

Description

[0001] This application is a divisional application of the invention patent application with the application date of June 18, 2008, application number 200880019212.7, and the name "synthetic bile acid composition, method and preparation". [0002] Related Application Cross Reference [0003] This application claims priority over U.S. Provisional Patent Application No. 60 / 945,035, filed June 19, 2007, and U.S. Provisional Patent Application No. 60 / 956,875, filed August 20, 2007; U.S. Utility Patent Application No. 12 / 035,339, filed February 21, 2008 and U.S. Utility Patent Application No. 12 / 153,446, filed May 16, 2008; and has priority over April 25, 2008 filed UK Patent Application No. 0807615.0, each of which is hereby incorporated by reference in its entirety. technical field [0004] In general, the present invention relates to bile acids and related compositions and methods. In one aspect, the present invention relates to deoxycholic acid and related compositions, usef...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07J9/00A61K31/575A61K45/06A61P3/04A61K8/63A61Q19/06
CPCA61K31/575A61K45/00A61Q19/06C07J9/00C07J9/005A61K8/63C07J1/0011C07J1/0022C07J13/007A61P3/00A61P3/04A61P3/06Y02P20/55
Inventor 罗伯特·M·莫里亚蒂纳撒尼尔·E·戴维纳迪尔·阿梅杜迪恩·马哈茂德阿昌佩塔·拉坦·普拉萨德罗伊·A·小斯瓦尔英根约翰·格雷戈里·里德阿希拉·库马尔·萨胡
Owner 艾尔健销售有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products